PMID: 20626337Jul 16, 2010Paper

Current place of beta-blockers in the treatment of hypertension

Current Vascular Pharmacology
Agata Bielecka-DabrowaMaciej Banach

Abstract

Hypertension represents the most common cardiovascular risk factor, affecting more than 25% of the adult population in developed societies. Although beta-blockers have been previously shown to effectively reduce blood pressure and have been used for hypertension treatment for over 40 years, their effect on cardiovascular morbidity and mortality in hypertensive patients remains controversial and their use in uncomplicated hypertension is currently still under debate. According to the previous recommendations beta-blockers should not be preferred as first-line therapy in hypertension patients. This review summarizes the current knowledge on application of beta-blockers in patients with hypertension and discusses the most recent guidelines of the European Society of Hypertension (2009) on beta-blockers applications.

Citations

Dec 5, 2012·BMC Nephrology·Beata Franczyk-SkóraJacek Rysz
Apr 9, 2011·Current Cardiovascular Risk Reports·Agata Bielecka-DabrowaMaciej Banach
Apr 27, 2011·Expert Opinion on Pharmacotherapy·Maciej BanachJacek Rysz
Oct 28, 2010·Expert Opinion on Pharmacotherapy·Maciej Banach, Jacek Rysz
Nov 28, 2015·Nutrition & Metabolism·Simona GranataGianluigi Zaza
Mar 31, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maciej BanachAdrian Covic
Feb 26, 2015·Journal of Pharmacy Practice·Lindsay Hahn, Martin Hahn
Jan 29, 2017·Expert Opinion on Pharmacotherapy·Yogita RochlaniWilbert S Aronow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Annals of Medicine
Dariusz KozlowskiMaciej Banach
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
Sun-Hee ParkBengt Lindholm
Heart & Lung : the Journal of Critical Care
George Nikolić
© 2021 Meta ULC. All rights reserved